Atlas Trials

Efficacy and Safety of Lenalidomide as a Treatment for Recurrent or Refractory POEMS Syndrome Trial

Clinical trial NCT02193698 · COMPLETED

Trial details

NCT number
NCT02193698
Sponsor
Chiba University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
POEMS Syndrome
Start date
2014-07-01
Primary completion
2015-10-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.